Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07064824 · ClinicalTrials.gov registry record · NA

Adaptive Cell Phone Support (ACPS)

A NA study, sponsored by Children's Hospital Los Angeles.

Not yet
Registry status
NA
Development phase
96
Enrollment target

NCT07064824: Clinical Trial NA study, sponsored by Children's Hospital Los Angeles.

NCT07064824 is a NA study that has not yet begun recruiting, run by Children's Hospital Los Angeles. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07064824, a NA study, has not yet begun recruiting, sponsored by Children's Hospital Los Angeles.

NOT YET RECRUITING
Registry status
NA
Development phase
96 participants
Enrollment target

Study Summary

The goal of this pilot clinical trial is to test a mobile health intervention for promoting medication adherence in a population of adolescents and young adults with chronic health conditions. The main question it aims to answer is: -Is an adaptive intervention (personalizing the intensity of support based on patients' needs) efficacious for promoting medication adherence Researchers will compare the adaptive intervention to automated text message reminders see if the adaptive intervention shows stronger positive effects on medication adherence.

Primary Outcome

Higher scores indicate greater ease with which users can use technology to achieve a particular goal; the minimum value of this questionnaire is 1 and the maximum value is 7.

Interventions

  • BEHAVIORAL Adaptive Cell Phone Support
  • BEHAVIORAL Computer-Delivered Cell Phone Support
  • BEHAVIORAL Automated Text Reminders

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2027-08-01
Est. Completion 2030-07-30
Phase NA
Children's Hospital Los Angeles

119 total trials

What is known before NCT07064824 opens enrollment

NCT07064824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 3 interventions - of which Adaptive Cell Phone Support is the first listed.

NCT07064824 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07064824 about?

NCT07064824 is a clinical study titled "Adaptive Cell Phone Support (ACPS)". The goal of this pilot clinical trial is to test a mobile health intervention for promoting medication adherence in a population of adolescents and young adults with chronic health conditions. The main question it aims to answer is: -Is an adaptive intervention (personalizing the intensity of suppo...

What is the current status of trial NCT07064824?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2027-08-01. Estimated completion is 2030-07-30.

What interventions are being tested in trial NCT07064824?

The interventions under investigation include: Adaptive Cell Phone Support (BEHAVIORAL), Computer-Delivered Cell Phone Support (BEHAVIORAL), Automated Text Reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT07064824?

This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07064824's enrollment target sits among peer trials

96 925th of 2000 higher than 1,070 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07064824, the US trial registry maintained by the National Library of Medicine. NCT07064824 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.